CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

TVTXTravere Therapeutics, Inc.

NASDAQ · PHARMACEUTICAL PREPARATIONS
Last close $58.88 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPHARMACEUTICAL PREPARATIONS
Market cap$5.55B
CountryUSA
RECENT INSIDER TRADES
  • 2026-09-17 · Dube Eric M (CHIEF EXECUTIVE OFFICER) · SELL
  • 2026-09-17 · Heerma Peter (EVP, CHIEF COMMERCIAL OFFICER) · OTHER
  • 2026-09-17 · Dube Eric M (CHIEF EXECUTIVE OFFICER) · OTHER
  • 2026-09-17 · Heerma Peter (EVP, CHIEF COMMERCIAL OFFICER) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders336
Shares held160,991,586
Value$6.55B
Percent of shares outstanding170.79%
As of quarter end2026-06-30
RECENT NEWS
  • TVTX: Kuehn Law Encourages Investors of Travere Therapeutics, Inc. to Contact Law Firm
  • Travere Therapeutics appoints new CEO
  • Travere Therapeutics CEO Eric Dube to step down in December
  • Travere Therapeutics EVP Peter Heerma sells $17.8m in company stock
  • Travere Therapeutics CFO Cline sells $3.1m in company stock
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS